The fact that RGC’s IC50 for the degradation of S100A4 in and the migration of the human breast cancer cell line MDA-MB-231 are similar at 3.2 and 3.5 nM, respectively (Figure 3D,H) (Supplementary Table S3) suggests that RGC is operating through a common mechanism. This evidence concerns the gene S100A4 and breast cancer.